Core Insights - The article highlights the approval of two innovative medical devices in China: the "Fully Automatic Cell Morphology Analyzer" by Shenzhen Mindray Bio-Medical Electronics Co., Ltd. and the "X-ray Computed Tomography Equipment" by Neusoft Medical Systems Co., Ltd. [1][2] Group 1: Product Overview - The Fully Automatic Cell Morphology Analyzer is designed for classifying and counting white blood cells and nucleated red blood cells from human peripheral blood samples, enhancing accuracy in identifying abnormal samples through advanced imaging and deep learning technologies [3]. - The X-ray Computed Tomography Equipment, NeuViz P10, is noted as China's first photon counting CT and the world's first 8cm wide photon counting CT, utilizing a novel detection method for improved resolution and lower radiation doses [9][11]. Group 2: Company Profiles - Mindray Medical, established in 1991 and headquartered in Shenzhen, is the largest medical device manufacturer in China, with a global presence in 31 countries and a strong focus on patient monitoring, in vitro diagnostics, and medical imaging systems [5]. - Neusoft Medical, founded in 1998, is a core medical imaging equipment company under Neusoft Group, providing a wide range of imaging solutions and services, and has products in over 110 countries [12]. Group 3: Financial Performance - In 2024, Mindray reported an annual revenue of 36.73 billion yuan, a year-on-year increase of 5.1%, with a net profit of 11.67 billion yuan, reflecting a growth of 0.7% [7]. - For the first quarter of 2025, Mindray's revenue was 8.24 billion yuan, showing a decline of 12% year-on-year, with a net profit of 2.63 billion yuan, down 16.7% [7].